Skip to content

Clinical trial to study different methods of induction agents to induce labour

Comparison of efficacy of different modes of induction in predicting the outcome of labour- A Randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019614
Enrollment
300
Registered
2019-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Active Control group Prostaglandin E2 gel: Prostaglandin E2 gel 0.5mg vaginally maximum 3doses 6hrs apart Control Intervention1: Active Control group Oral Misoprostol: Misoprostol 25mc

Sponsors

Joseph nursing home
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: GA more than 37weeks,irrespective of parity Singleton,cephalic Intact membranes Unfavourable cervix Reassuring Cardiotocography

Exclusion criteria

Exclusion criteria: Fetal malpresentation Rupture of membranes Multifetal gestation Non reassuring FHR changes Fetal growth restriction Fetal demise Prev LSCS or any uterine surgery Anomalous fetus

Design outcomes

Primary

MeasureTime frame
1.Time interval between induction and active phase of labour, 2.Time interval between induction and delivery 3.Patients who had vaginal delivery within 24hours from inductionTimepoint: Time of induction to 72hours maximum

Secondary

MeasureTime frame
1.Mode of delivery, 2.Maternal complications, 3.Fetal outcomesTimepoint: Intrapartum to 48hrs from delivery

Countries

India

Contacts

Public ContactDr Kurian Joseph

Joseph nursing home

drkurian@gmail.com9840599969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026